Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases

被引:72
作者
Fournié, GJ
Cautain, B
Xystrakis, E
Damoiseaux, J
Mas, M
Lagrange, D
Bernard, I
Subra, JF
Pelletier, L
Druet, P
Saoudi, A
机构
[1] Hop Purpan, INSERM U28, Inst Federat Rech IFR 30, F-31059 Toulouse, France
[2] Univ Maastricht, Dept Immunol, Maastricht, Netherlands
[3] Univ Toulouse 3, F-31062 Toulouse, France
关键词
D O I
10.1034/j.1600-065x.2001.1840114.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The understanding of the mechanisms of immune tolerance and the unravelling of the pathophysiology of autoimmune diseases rely on animal models. In this respect, BN and LEW rats represent models of choice to study immune-mediated diseases from the cellular and genetic points of view. indeed, BN and LEW rats are extremes with respect to their polarisation of the immune response as well as their susceptibility to autoimmune diseases. LEW rats are susceptible to Th1-mediated autoimmune diseases while BN rats are highly susceptible to Th2-mediated autoimmune disease. Comparison of the T cell compartment between LEW and BN rats revealed several important differences. 1) A MHC-dependent quantitative difference that is due to a defect in the CD8 T cell compartment in BN rats. 2) A qualitative MHC-independent difference that is related to a high frequency of CD45RC(low) CD4 and CD8 T cell subsets, producing IL-4, IL-13, IL-10 and TGF-beta in BN rats as compared to LEW rats. 3) Interestingly, the genetic studies showed that susceptibility to Th1-mediated experimental autoimmune encephalomyelitis, and to Th2-mediated disorders triggered by gold salts as well as the difference in the CD45RC(high)/CD45RC(low) ratio between LEW and BN rats are genetically determined by regions on chromosomes 9, 10 and 20.
引用
收藏
页码:145 / 160
页数:16
相关论文
共 131 条
[61]  
KIELY PDW, 1995, LAB INVEST, V73, P284
[62]  
Krishnan L, 1996, J IMMUNOL, V156, P644
[63]   Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease [J].
Lafaille, JJ ;
VandeKeere, F ;
Hsu, AL ;
Baron, JL ;
Haas, W ;
Raine, CS ;
Tonegawa, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (02) :307-312
[64]   NONCYTOTOXIC, IL-4, IL-5, IL-10 PRODUCING CD8+ T-CELLS - THEIR ACTIVATION AND EFFECTOR FUNCTIONS [J].
LEGROS, G ;
ERARD, F .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :453-457
[65]   ROLE OF COMPLEMENT IN PATHOGENESIS OF EXPERIMENTAL AUTO-IMMUNE MYASTHENIA-GRAVIS [J].
LENNON, VA ;
SEYBOLD, ME ;
LINDSTROM, JM ;
COCHRANE, C ;
ULEVITCH, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 147 (04) :973-983
[66]   TH1 AND TH2 CD4(+) T-CELLS IN THE PATHOGENESIS OF ORGAN-SPECIFIC AUTOIMMUNE-DISEASES [J].
LIBLAU, RS ;
SINGER, SM ;
MCDEVITT, HO .
IMMUNOLOGY TODAY, 1995, 16 (01) :34-38
[67]   EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS AND MYASTHENIA-GRAVIS - BIOCHEMICAL AND IMMUNOCHEMICAL ASPECTS [J].
LINDSTROM, JM ;
LENNON, VA ;
SEYBOLD, ME ;
WHITTINGHAM, S .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 274 (MAY28) :254-274
[68]   PATHOLOGICAL MECHANISMS IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS .1. IMMUNOGENICITY OF SYNGENEIC MUSCLE ACETYLCHOLINE-RECEPTOR AND QUANTITATIVE EXTRACTION OF RECEPTOR AND ANTIBODY-RECEPTOR COMPLEXES FROM MUSCLES OF RATS WITH EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS [J].
LINDSTROM, JM ;
EINARSON, BL ;
LENNON, VA ;
SEYBOLD, ME .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (03) :726-738
[69]   PATHOLOGICAL MECHANISMS IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS .2. PASSIVE TRANSFER OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS IN RATS WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODIES [J].
LINDSTROM, JM ;
ENGEL, AG ;
SEYBOLD, ME ;
LENNON, VA ;
LAMBERT, EH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (03) :739-753
[70]   PASSIVE TRANSFER OF EXPERIMENTAL MYASTHENIA-GRAVIS VIA ANTIGENIC MODULATION OF ACETYLCHOLINE-RECEPTOR [J].
LOUTRARI, H ;
KOKLA, A ;
TZARTOS, SJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (09) :2449-2452